首页> 外文期刊>The Medicine Forum >Thrombotic Thrombocytopenic Purpura: A Review of the Disease Entity, its Clinical and Laboratory Features, and Management Strategies
【24h】

Thrombotic Thrombocytopenic Purpura: A Review of the Disease Entity, its Clinical and Laboratory Features, and Management Strategies

机译:血栓性血小板减少性紫癜:疾病实体,其临床和实验室特征和管理策略的审查。

获取原文
           

摘要

Case 1 The patient is a 47-year-old female with a history of coronary artery disease, hypertension, asthma, diabetes and obstructive sleep apnea who presented to an outside hospital with shortnessof breath and lethargy. The patient was found to be in diabetic ketoacidosis, which was treated with an insulin drip. She also had a platelet count of 8 x 109/L on initial laboratory studies. She was presumed to have immune thrombocytopenic purpura(ITP) and treated with five days of intravenous immunoglobulin(IVIG) without improvement. She was transferred to Thomas Jefferson University Hospital for further management.
机译:病例1该患者是一位47岁的女性,具有冠心病,高血压,哮喘,糖尿病和阻塞性睡眠呼吸暂停的病史,因呼吸急促和嗜睡而到一家外院就诊。发现该患者患有糖尿病性酮症酸中毒,接受了胰岛素滴注治疗。在最初的实验室研究中,她的血小板计数为8 x 109 / L。据推测她患有免疫性血小板减少性紫癜(ITP),并接受了为期五天的静脉注射免疫球蛋白(IVIG)治疗,但无改善。她被转到托马斯·杰斐逊大学医院接受进一步治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号